Why is Natco Pharma falling/rising?

As of 10-Oct, Natco Pharma Ltd. is experiencing a rise in its stock price, currently at 844.55, reflecting an increase of 31.0 points or 3.81%. The stock has shown positive momentum, gaining 4.49% over the last two days and outperforming its sector by 2.58% today. It opened with a gain of 3.38% and reached an intraday high of Rs 862.65, which is a 6.04% increase. Despite this short-term gain, the stock has underperformed over the longer term, with a year-to-date decline of 39.11% and a one-year return of -41.14%. Factors contributing to the recent price movement include high management efficiency indicated by a return on equity (ROE) of 15.57%, a low debt-to-equity ratio, and healthy long-term growth in operating profit. However, the stock's performance has been hindered by flat results in June and below-par performance over both the long and near term.
In the broader market context, Natco Pharma's short-term return of 2.61% over the past week outpaces the benchmark Sensex, which has gained 1.59% in the same period. While the stock has shown some positive movement recently, it still faces challenges due to its significant underperformance compared to the broader market over the past year and three years. The high institutional holdings at 21.33% suggest that knowledgeable investors are backing the stock, but the overall negative sentiment from its long-term performance may continue to weigh on investor confidence.